T1	duration 110 117	16-week
T2	intervention 332 348	aerobic exercise
T3	No-of-participants 415 418	319
T4	eligibility 419 440	young sedentary women
T5	outcome-Measure 565 582	IGF-I and IGFBP-1
T6	outcome-Measure 584 591	IGFBP-2
T7	outcome-Measure 597 604	IGFBP-3
T8	outcome 629 647	Exercise adherence
T9	outcome 661 674	dropout rates
T10	control 696 710	control groups
T11	intervention-value 716 721	21.7%
T12	control-value 726 731	14.5%
T13	outcome 777 823	change from baseline in IGFBP-3 concentrations
T14	outcome 825 839	IGFBP-3 levels
